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Brief Research Report
In 1997, a severe influenza-like illness was described in 
human patients in several countries in Southeast Asia. Diag-
nostic testing determined that they had been infected with a 
highly pathogenic avian Influenza A virus (HPAI) from the 
H5N1 subtype.2,9,11 Infection of human beings by avian 
influenza virus is uncommon, at least in part because avian 
influenza viruses prefer α-2,3 sialic acid glycoprotein recep-
tors. The relatively few α-2,3 viral receptors in the upper 
respiratory tract of human beings may reduce susceptibility 
to infection by airborne avian virus and decrease the likeli-
hood of transmission to a human host.10 Nonetheless, direct 
interspecies transmission of avian influenza to human beings 
is possible and is postulated to have been responsible for the 
1918 influenza pandemic.10
Beyond the high mortality induced in poultry, the greatest 
concern with HPAI is the possibility of the virus adapting 
and establishing itself within the human population either 
through regular interspecies infection and horizontal trans-
mission within the human population or through adaptation 
in an intermediate host, such as the pig. Evidence suggests 
the pig can serve as a “mixing vessel” supporting both human 
and avian influenza virus replication, attributed to the pres-
ence of both α-2,6 (human-like) and α-2,3 (avian-like) sialic 
acid receptors in the upper respiratory tract.3 In contrast to 
human beings who in severe cases may require medical 
attention after infection with HPAI H5N1, pigs are only 
mildly affected by experimental or natural infection, sug-
gesting the clinical impact of the virus on swine is mini-
mal.1,6,7 The lack of clinical disease could result in 
underreporting of HPAI H5N1 infection in pigs, allowing the 
virus to persist in a small number of pigs within a population 
and thus potentially facilitating adaptation. An HPAI H5N1 
virus has been isolated from swine in Indonesia that expressed 
a preference for the human-like α-2,6 sialic acid receptor 
suggesting that viral adaptation had occurred.7 Because of 
the potential risk that HPAI H5N1 infection of pigs could 
pose to human health, as well as the potential negative 
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Abstract. A potential mechanism by which highly pathogenic avian Influenza A virus subtype H5N1 could more readily 
infect human beings is through the infection of and adaptation in pigs. To detect the occurrence of such infection, monitoring 
of pig populations through serological screening would be highly desirable. In the current study, hemagglutination inhibition 
assays were able to detect antibodies against H5N1 developed in pigs, but because of antigenic variation between clades, 
the use of multiple virus strains were required. Whole recombinant virus and recombinant hemagglutinin antigen enzyme-
linked immunosorbent assays (ELISAs) were generated that could detect antibody against multiple H5N1 strains, but which 
also detected antibody against endemic swine influenza viruses. A recombinant hemagglutinin antigen-based ELISA was as 
effective as the whole virus antigen ELISAs in detecting antibody against the H5N1 virus strains used and eliminated nearly 
all of the cross-reactivity with non-H5N1 virus antibody. The current study also highlighted the difficulty in establishing a 
decision (cutoff) value that would effectively counterbalance nonspecific reactivity against sensitivity. The results provide 
important information and considerations for the development of serological screening assays for highly pathogenic avian 
H5N1 viruses.
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economic impact on the swine industry itself, development 
of screening tests that can identify H5N1 HPAI infection in 
pigs would be valuable tools in preventing establishment of 
this virus in swine populations.8 A serologic assay would be 
a good adjunct to polymerase chain reaction (PCR)–based 
tests for virus as antibody will circulate in serum for a longer 
duration than virus will be shed in nasal secretions.
To be available for use under biosafety level (BSL) 2 con-
ditions at which veterinary diagnostic laboratories operate, 
H5N1 viruses in the assay would need to be attenuated. Three 
recombinant H5N1 (rH5N1) viruses (A/Vietnam/1203/04 
[rVN04], A/Whooper Swan/Mongolia/244/05 [rWS05], and 
A/Japanese White Eye/Hong Kong/1038/06 [rJWE06]f) were 
created using reverse genetics as previously described,3 to 
attenuate the viruses for use in a BSL2+ environment.a 
Briefly, the viruses encode the hemagglutinin (HA) and neur-
aminidase genes from 1 of the H5N1 isolates as well as the 
remaining 6 genes from A/Puerto Rico/8/34 (PR8). The 
viruses were grown in either embryonated chicken eggs or 
Madin–Darby canine kidney cells.b The HA units (HAU)/ml 
were determined for each virus using 2-fold serial dilutions of 
the virus preparations in phosphate buffered saline (PBS) and 
incubating with 1% turkey red blood cells (RBCs) in PBS. 
The virus solutions were placed in 100-mm dishes and then 
ultraviolet (UV)-inactivated for 3 min using a UV crosslinker.c 
Ultraviolet inactivation of the virus was confirmed to be rep-
lication deficient using an immunocytochemistry TCID
50
 
assay, as previously described.4 Virus suspensions were 
diluted with PBS to a concentration of 128 HAU/ml, with the 
exception of the initial preparation of rWS05 that had a con-
centration of 96 HAU/ml.
To obtain H5N1-specific antiserum for use in the devel-
opment of immunological assays for screening of H5N1 
antibodies, 5-week-old pigs were vaccinated with each of the 
3 recombinant viruses. The vaccine preparations also con-
tained a final concentration of 20% v/v adjuvant.d Pigs were 
vaccinated and booster doses administered at 14 and 33 days 
post initial vaccination (DPV). Serum samples were col-
lected prior to vaccination and at 8, 14, 22, 33, and 40 DPV. 
All animal work was performed in compliance with the 
National Animal Disease Center Institutional Animal Care 
and Use Committee guidelines.
Antibody titers for the serum samples were determined 
using hemagglutination inhibition (HI) assay. Serum sam-
ples were treated with receptor destroying enzyme (RDEe; 
100 µl of serum to 300 µl of RDE solution) and incubated 
overnight at 37°C. After RDE treatment, serum was brought 
to a final 1:10 dilution by the addition of physiological saline 
(0.85% w/v NaCl solution) and serially diluted into 96-well 
U-bottom plates using 2-fold serial dilutions ranging from 
1:10 to 1:2,560. An equivalent volume of virus at 8 HAU/ml 
concentration was added to each well and incubated at room 
temperature for 1 hr. Another volume of 1% turkey RBCs in 
PBS was added, incubated for another hour, and HI titers 
were determined as the reciprocal of the highest dilution 
completely inhibiting agglutination. Reported HI titers are 
the geometric mean of 3 individual HI assay replicates. At 8 
DPV, rVN04- and rJWE06-vaccinated pigs had HI titers of 
80, while rWS05 pigs had HI titers of 160. By 40 DPV, geo-
metric mean HI titers increased to 508 for both rVN04- 
vaccinated pigs, 1208 and 806 for rWS05-vaccinated pigs, 
and 640 for rJWE06-vaccinated pigs.
Additionally, HI assays were performed using the serum 
samples collected at 40 DPV to determine the relative HI anti-
body cross-reactivity between the rH5N1 viruses (Table 1). 
The heterospecific HI titers differed substantially depending 
on the viral strain used for antibody detection. The HI assays 
using rVN04 or rWS05 viruses against heterologous serum 
samples differed by 4- to 16-fold from HI titers measured 
against homologous virus. However, when the rJWE06 virus 
was used for detection of antibody in serum from pigs vacci-
nated with rVN04 and rWS05, the HI titers of the heterolo-
gous serum samples were similar to those measured in 
homologous serum (within a 2-fold difference). These results 
indicate that, similar to HI tests against endemic swine 
viruses, the ability to detect antibody against H5N1 in swine 
serum using HI assays is dependent on the viral strains used 
for detection and would likely require use of multiple strains 
in order to assure detection of all virus clades.5
To determine if antigenic variation among HPAI H5N1 
viruses would similarly interfere with enzyme-linked immu-
nosorbent assay (ELISA) format serologic testing, single 
antigen indirect ELISAs were generated using each rH5N1 
virus. Additionally, to determine if potential cross-reactivity 
issues were characteristic of the hemagglutinins (as opposed 
to other virus proteins), a commercially available recombi-
nant HA protein (rHA) from A/Vietnam/1203/04k also was 
used as an antigen. Components for the ELISAs were opti-
mized using a checkerboard format to compare concentra-
tion of antigens (2–256 HAU/ml of each of the rH5N1 
viruses or 0.03–4 µg/ml recombinant HA protein from A/
Vietnam/1203/05f) in different combinations with homolo-
gous serum sample dilutions (1:10–1:20,480). Additional 
assays were performed to optimize the conjugate antibody 
dilution (1:500–1:64,000). Using the optimized conditions 
Table 1. Heterospecific geometric mean hemagglutination 
inhibition assay titers comparing antibody titers against the 
recombinant (r)H5N1 viruses at 40 days postvaccination.*
Virus
Pig rVN04 rWS05 rJWE06
VN-1 508 80 320
VN-2 508 40 320
WS-1 320 1,280 1,280
WS-2 160 806 640
JWE-1 40 80 640
JWE-2 40 80 905
* Boldface indicates homologous hemagglutination inhibition assay titers.
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(Table 2), platesg were coated with 100 µl of diluted rH5N1 
virus or rHA resuspended in PBS and incubated overnight at 
37°C. Plates were washed 3 times using PBS with 0.05% 
Tween 20 (PBST) and tapped onto paper towels between 
washes to remove residual liquid. Serum samples were then 
diluted with ELISA diluent (PBS with 0.5% gelatin, 0.15% 
Tween 20, and 4% goat serum), and 100 µl of a diluted sam-
ple was added to a well and incubated at room temp for 1.5 hr. 
After the plates were washed 3 times with PBST, 100 µl of 
anti-swine HRPh diluted 1:500 in ELISA diluent was added 
to each well and incubated for 1 hr at room temperature. The 
plates were washed 3 times with PBST prior to the addition 
of 100 µl of substrate (10 mg of o-phenylenediamine in 20 
ml of 0.05 M phosphate citrate buffer, containing 0.03% 
sodium perborate). The plates were incubated until color 
development was complete (approximately 1 min) and 
stopped with 1 N sulfuric acid. Using a plate reader,g sample 
absorbance (optical density [OD]) was determined at a wave-
length of 492 nm. The serum from the pigs vaccinated with 
the attenuated H5N1 viruses were tested by the above-
described ELISAs.
Because nearly all conventional swine have antibody to 
multiple endemic swine influenza viruses, cross-reactivity 
by these antibodies in the H5N1 ELISAs would preclude 
their use for surveillance. Serum from pigs infected in a pre-
vious study with influenza viruses (A/Swine/Wisconsin/
R33f/01 [H1N2], A/Swine/Iowa/40776/93 [H1N1], A/
Swine/Iowa/35233/99 [H1N1], A/Swine/Texas/4199-2/98 
[H3N2], and A/Swine/Wisconsin/R7c/01 [H3N2]), 1 pig per 
virus, were also tested.5 Homologous HI titers for the 
endemic swine serum samples ranged from 160 to 1,280.
All 3 recombinant ELISAs were able to detect antibody, 
both homologous and heterologous, in nearly all samples col-
lected after 22 DPV but only inconsistently in serum samples 
collected earlier. The VN04 ELISA was able to detect anti-
body in more of the earlier samples. The HI test was more 
sensitive for all 3 recombinant viruses, detecting geometric 
mean antibody titers of 80–160. However, all 3 ELISAs also 
detected antibody in 8 of 10 of the non-H5 serum samples 
(5 samples run in 2 replicates). The rHA ELISA detected anti-
body in nearly all samples from the recombinant H5–vaccinated 
pigs collected after 22 DPV. However, antibody was detected 
by this test in only 2 of the replicate samples of non-H5 serum, 
and the OD values were just above the cutoff value.
Data from 2 independent ELISA replicates were com-
bined and analyzed using receiver operating characteristics 
(ROC)i for determination of the cutoff values and calcula-
tion of the sensitivity and specificity for each assay (Table 
3). For ROC analysis of these assays, all non-H5 serum 
samples collected between 8 DPV and 40 DPV, regardless 
of the virus used for vaccination, were considered positive. 
To minimize the potential for false positive results (which 
could pose serious economic difficulties for a herd under 
test), cutoff values were selected for each assay that elimi-
nated detection of non-H5N1 serum samples; at these cutoff 
values, all 4 ELISAs had specificities of 100% (Table 3). 
Based on these parameters, the rWS05 and rJWE06 ELISAs 
appeared to have similarly low sensitivities of 37% and 
38%, respectively. The rVN04 ELISA out-performed both 
of the other whole virus assays with a sensitivity of 48%. 
Analyzed in this manner, the results suggest that the major-
ity of positive samples from rH5N1-vaccinated pigs were 
undetected with this assay. This apparent lack of sensitivity 
may have been artificially enhanced as a result of the deci-
sion threshold imposed by the relatively high cross-reactiv-
ity with the non-H5 antibodies. This cross-reactivity could 
be expected since the recombinant viruses contain a PR8 
influenza backbone ancestrally related to classical swine 
influenza.
In contrast, the rHA antigen ELISA had a greater ability 
to differentiate between anti-H5 and anti–non-H5 antibody. 
By ROC analysis, at the cutoff value (the highest OD value 
at which no non-H5 antibody was detected but at which 
H5N1 specificity was 100%) the H5N1 sensitivity was 60%, 
which is substantially higher than that of the whole recombi-
nant virus assays. These results suggest rHA ELISAs may be 
preferable to recombinant whole virus assays. Selecting a 
lower cutoff value would result in an increase in sensitivity, 
but would decrease the ability of the assay to differentiate 
between endemic swine influenza H1 and H3 subtypes and 
H5N1 serum samples.
Serological assays provide a number of benefits when 
screening large populations for the prevalence of H5N1 influ-
enza in pigs, especially the ability to detect the occurrence of 
Table 2. Optimized enzyme-linked immunosorbent assay 
(ELISA) protocol conditions determined from checkerboard 
analysis for the whole virus and recombinant hemagglutinin 
ELISA assays.*
rVN04 rWS05 rJWE06 rHA
Sample dilution 1:160 1:160 1:320 1:80
Antigen concentration 64 HAU 64 HAU 256 HAU 4 µg/ml
Conjugate dilution 1:500 1:500 1:500 1:500
*  HAU = hemagglutinin units.
Table 3. Specificity and sensitivity for each enzyme-linked 
immunosorbent assay determined through receiver operating 
characteristic analysis and calculation of cutoff values.
Assay Cutoff * Specificity (%) Sensitivity (%)
rVN04 1.357 100 48
rWS05 0.930 100 37
rJWE06 0.647 100 38
rHA 0.503 100 60
* Only cutoff values with non-H5N1 sensitivity equaling zero  
were considered (see Supplemental Tables 1–4 online at  
http://jvdi.sagepub.com/supplemental).
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infection for an extended period of time after active viral rep-
lication has ceased. As stated earlier, pigs may present with 
subclinical symptoms and go unnoticed through the course of 
infection, making acquisition of viral RNA for use in real-
time RT-PCR assays difficult. This study utilized 3 different 
serological assays and illustrated the hurdles encountered 
when analyzing serum samples from potentially H5N1 
infected pigs.
Results obtained in the current study indicate whole 
recombinant H5N1 ELISAs prepared as described would 
not be useful because of cross-reactivity with antibody 
against endemic swine viruses, but that the rHA indirect 
ELISA format may be more promising. In its current state, 
the rHA ELISA would not be useful as a differential diag-
nostic tool, but could be useful as a surveillance tool. 
Decreasing the cross-reactivity of the assay to non-H5N1 
serum samples may increase the sensitivity, by allowing 
lower cutoff values. Such assay conditions in which detec-
tion of non-H5N1 sera is minimized may have been 
achieved by including non-H5N1 sera during concentra-
tion optimization procedures during development. Future 
work is needed to further optimize the ELISA to increase 
sensitivity and minimize the effects that heterosubtypic 
antibodies have on specificity. Even if sensitivity of the 
rHA ELISA could be improved through methodology 
improvements, antigen variation among H5 hemaggluti-
nins might require use of a multiplex of different rHAs. 
The differences in cross-reactivity between H5 antigens 
exhibited in both HI and the whole recombinant virus ELI-
SAs in the present study would suggest that as another dif-
ficulty.
A number of the commercially available H5N1 ELI-
SAs for avian species also use rHA antigen to coat the 
plates, such as developed by Gentaur j and Green Spring.i 
Comparison of the 4 ELISA assays described herein with 
these commercially available H5N1-specific ELISAs may 
have proven valuable in development efforts. The other 
H5N1 ELISAs utilizing a similar platform appear to be 
primarily developed for use with avian serum samples and 
would require both modification and optimization of the 
assay for use with swine serum samples. However, such 
modification of a commercially available avian H5N1 
ELISA kit may be a more cost efficient approach. In con-
clusion, this work lays the groundwork for the develop-
ment of a serological assay for detecting antibodies 
against H5N1 that could be standardized for diagnostic 
use in pigs.
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